OTUD3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.237800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.639200E-01
Normal-vs-Stage2
3.761600E-01
Normal-vs-Stage3
1.594170E-01
Normal-vs-Stage4
9.228400E-01
Stage1-vs-Stage2
7.161200E-01
Stage1-vs-Stage3
8.824400E-02
Stage1-vs-Stage4
7.242200E-01
Stage2-vs-Stage3
1.041770E-01
Stage2-vs-Stage4
4.229400E-01
Stage3-vs-Stage4
1.298210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.438000E-01
Normal-vs-AfricanAmerican
3.738000E-01
Normal-vs-Asian
6.501000E-01
Caucasian-vs-AfricanAmerican
6.215400E-01
Caucasian-vs-Asian
8.743200E-01
AfricanAmerican-vs-Asian
6.605400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.016000E-01
Normal-vs-Female
3.589600E-01
Male-vs-Female
5.429600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.605200E-01
Normal-vs-Age(41-60Yrs)
7.070000E-01
Normal-vs-Age(61-80Yrs)
3.855000E-01
Normal-vs-Age(81-100Yrs)
8.467900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.719200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.167200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.290160E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.433700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.255400E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.918300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.695350E-01
Normal-vs-Daily Drinker
2.024400E-01
Normal-vs-Weekly Drinker
3.062400E-01
Normal-vs-Occasional Drinker
7.865600E-01
Normal-vs-Social Drinker
3.949800E-01
Non Drinker-vs-Daily Drinker
8.563600E-01
Non Drinker-vs-Weekly Drinker
5.514000E-01
Non Drinker-vs-Occasional Drinker
7.787900E-02
Non Drinker-vs-Social Drinker
4.223200E-01
Daily Drinker-vs-Weekly Drinker
6.701800E-01
Daily Drinker-vs-Occasional Drinker
1.311000E-01
Daily Drinker-vs-Social Drinker
5.335000E-01
Weekly Drinker-vs-Occasional Drinker
3.133800E-01
Weekly Drinker-vs-Social Drinker
8.442200E-01
Occasional Drinker-vs-Social Drinker
3.998600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.936800E-01
Normal-vs-Grade 2
1.697630E-01
Normal-vs-Grade 3
2.673200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.390400E-01
Grade 1-vs-Grade 3
1.467640E-01
Grade 1-vs-Grade 4
2.936800E-01
Grade 2-vs-Grade 3
8.557500E-02
Grade 2-vs-Grade 4
1.697630E-01
Grade 3-vs-Grade 4
2.673200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.579630E-01
Normal-vs-NonDiabetic
4.843800E-01
Diabetic-vs-NonDiabetic
8.731700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.886400E-01
Normal-vs-NoPancreatitis
3.992400E-01
Pancreatitis-vs-NoPancreatitis
7.659400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.724600E-01
Normal-vs-N1
3.412400E-01
N0-vs-N1
6.015400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.229200E-01
Normal-vs-TP53-NonMutant
7.362200E-01
TP53-Mutant-vs-TP53-NonMutant
3.640400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
